ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Clearmind Medicine Inc

Clearmind Medicine Inc (CMND)

1.60
0.00
( 0.00% )
Updated: 18:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.60
Bid
1.58
Ask
8.50
Volume
-
0.00 Day's Range 0.00
1.25 52 Week Range 4.67
Previous Close
1.60
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CMND Latest News

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023...

Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial

  Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2023...

Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic-Derived Obesity Treatment in Pre-Clinical Trial

      Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic- Derived Obesity Treatment in Pre-Clinical Trial In a series of pre-clinical trials...

Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute

Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute U.S. Patent and Trademark Office extends protection of Clearmind's...

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial   VANCOUVER, Canada -- November 23, 2022 -- InvestorsHub NewsWire -- Clearmind...

SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment

  SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment   Pre-clinical trials based on the proprietary...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1001.61.61.600CS
4001.61.61.600CS
12001.61.61.600CS
26001.61.61.600CS
52-2.05-56.16438356163.654.671.258152.427549CS
156-17.3-91.534391534418.93301.25923023.69502409CS
260-13.4-89.3333333333153301.251211723.82595704CS

CMND - Frequently Asked Questions (FAQ)

What is the current Clearmind Medicine share price?
The current share price of Clearmind Medicine is $ 1.60
What is the 1 year trading range for Clearmind Medicine share price?
Clearmind Medicine has traded in the range of $ 1.25 to $ 4.67 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RVVRevive Therapeutics Ltd
$ 0.01
(100.00%)
2k
CVGRCity View Green Holdings Inc
$ 0.01
(100.00%)
200k
BAMMBody and Mind Inc
$ 0.035
(75.00%)
26.6k
URMFirst American Uranium Inc
$ 0.025
(66.67%)
4.1k
CRCLCorcel Exploration Inc
$ 0.15
(66.67%)
1,000
MINAMinas Metals Ltd
$ 0.01
(-33.33%)
5k
ENRTEnertopia Corp
$ 0.01
(-33.33%)
19k
ARWYArway Corporation
$ 0.04
(-33.33%)
3k
VENIVencanna Ventures Inc
$ 0.01
(-33.33%)
3.5k
BYTBYT Holdings Ltd
$ 0.04
(-27.27%)
8k
NFLDExploits Discovery Corp
$ 0.04
(-11.11%)
1.26M
HEATHillcrest Energy Technologies Ltd
$ 0.16
(-3.03%)
791.22k
VREOVireo Growth Inc
$ 0.78
(11.43%)
687.51k
BOLTBolt Metals Corp
$ 0.12
(-7.69%)
530.8k
CSSCascada Silver Corp
$ 0.04
(0.00%)
478k

CMND Discussion

View Posts
Penny chatter Penny chatter 4 months ago
Market cap 4.4 million is insane
👍️0
Penny chatter Penny chatter 4 months ago
Big market patented product.
👍️0
subslover subslover 4 months ago
Thank you, Penny. I wonder if this can work.
👍️0
Penny chatter Penny chatter 4 months ago
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

Source: GlobeNewswire Inc.?


Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received a new patent approval from the United States Patent and Trademark Office, marking another significant advancement in its proprietary MEAI-based binge behavior regulator program.

The approved patent claims cover, among other things, a method of regulating the consumption of alcoholic beverages and a method of controlling binge behavior through the administration of an amine aminoindane, including 5-methoxy-2-aminoindan (MEAI), the Company's innovative psychedelic molecule. This latest patent further bolsters Clearmind’s extensive intellectual property portfolio in the psychedelic sector, which now includes 29 granted patents across 19 patent families, with protections secured in key jurisdictions such as the U.S., Europe, China, and India.

Dr. Adi Zuloff-Shani, CEO of Clearmind, commented, “We are proud to continue leading the way in IP protection within this space. Expanding and maintaining our patent portfolio, particularly in the U.S., remains a key objective for us. We believe that we hold one of the largest portfolios in the market, covering our core areas: MEAI, binge behavior, addictions, mental disorders, as well as new psychedelic compounds and combinations identified and researched by our team.”

MEAI is a novel psychoactive molecule that reduces the desire to consume alcoholic beverages while providing a mild euphoric, alcohol-like experience. It holds the potential to transform the lives of millions who struggle with moderating their alcohol intake. Clearmind’s MEAI-based flagship treatment targets Alcohol Use Disorder (AUD) and weight loss. AUD is a widespread condition that ranges from mild to severe and is characterized by an individual’s inability to control their alcohol consumption despite adverse social, occupational, or health consequences. Clearmind’s MEAI may also be effective in treating binge drinking, a potentially life-threatening addiction.

👍️0
subslover subslover 4 months ago
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
Vancouver, Canada, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the submission of a patent application under the international Patent Cooperation Treaty (“PCT”) as part of the company’s ongoing collaboration with the with Yissum Research Development Company of the Hebrew University of Jerusalem (“Yissum”) pursuant to the exclusive licensing agreement that the Company entered into with Yissum.

This patent application refers to generation 3.0 of psychedelic compounds, methods of their preparation and uses thereof in the treatment of mental disorders and was developed by Prof. Dmitry Tsvelikhovsky of the Hebrew University of Jerusalem.

The PCT submission will allow the company to proceed to the national phase, which involves submitting applications to regional offices in various countries to seek patent protection in major jurisdictions like the US, Europe, China and India.

Dr. Adi Zuloff-Shani, CEO of Clearmind, commented, "Under the exclusive global license agreement we signed with Yissum, this patent submission, if approved, will secure the intellectual property rights of this important patent for the company. We strongly believe in the potential of psychedelic treatments to become a vital tool in treating, mental disorders and we see Clearmind, as a leading company in the space, continuing to drive innovation. We believe that this next generation psychedelic, featuring new and advanced molecules may offer an excellent therapeutic option to improve quality of life for patients suffering from mental disorders.”
👍️0
glenn1919 glenn1919 4 months ago
CMND.......................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 months ago
CMND...........................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 months ago
CMND...................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 months ago
CMND 10Q expected Friday 6/28
👍️0
glenn1919 glenn1919 6 months ago
CMND.....................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 6 months ago
Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment
👍️0
Awl416 Awl416 7 months ago
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment
👍️0
Monksdream Monksdream 8 months ago
And down it goes
👍️0
Monksdream Monksdream 9 months ago
CMND under $2
👍️0
Nealio Nealio 9 months ago
How many shares are outstanding for CMND? Thanks.
👍️0
Awl416 Awl416 9 months ago
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
👍️0
Monksdream Monksdream 9 months ago
CMND 10Q due 3/22
👍️0
Monksdream Monksdream 9 months ago
CMND 10Q due 3/15
👍️0
Awl416 Awl416 10 months ago
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
👍️0
Awl416 Awl416 10 months ago
Now now
👍️0
TIMGZ TIMGZ 10 months ago
REENA, HOPE U ARE DOING WELLL, ****SO MANY FISHES TO FRY****WAY TO GO***

HAPPY TRADING
👍️0
reena969 reena969 10 months ago
CMND..hmmm....delay in market response to the news regarding CMND,Traders have been occupied this morning due to CHEA, YTEN, and FDMT.(Traded all three for nice profits)
https://finance.yahoo.com/news/clearmind-medicine-receives-patent-approval-125100357.html
👍️0
reena969 reena969 10 months ago
Not yet still adding
Need those cheapie
👍️0
Bud-Wiser Bud-Wiser 10 months ago
Here WEEEEE GO a baby -BOOM
👍️0
Bud-Wiser Bud-Wiser 10 months ago
I’m loaded … I think this will be a solid week here
👍️0
TimeFades TimeFades 11 months ago
Time to load
👍️0
TimeFades TimeFades 11 months ago
Looks appetizing
👍️0
Monksdream Monksdream 11 months ago
CMND new 52 week low
👍️0
Monksdream Monksdream 11 months ago
CMND new 52 week low
👍️0
Monksdream Monksdream 11 months ago
CMND new 52 week low
👍️0
TheFinalCD TheFinalCD 11 months ago
$CMND Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement
https://newsfilter.io/articles/clearmind-medicine-inc-announces-pricing-of-24-million-registered-direct-and-private-placement-8bef08328438d3cb53724b7c9348a9a7
👍️0
Invest-in-America Invest-in-America 11 months ago
CMND: News about 'Psychiatric Mushrooms' to fix crazy drunks.
https://www.marketscreener.com/quote/stock/CLEARMIND-MEDICINE-INC-43371362/news/Clearmind-Medicine-Completed-Type-A-Meeting-with-the-FDA-45713831/
👍️0
Monksdream Monksdream 11 months ago
CMND new 52 week low
👍️0
Awl416 Awl416 1 year ago
Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment

I shouldn’t laugh especially with todays coke but I got a chuckle out of this
👍️0
weedtrader420 weedtrader420 1 year ago
NEWS OUT
👍️0
Awl416 Awl416 1 year ago
There she goes again
👍️0
weedtrader420 weedtrader420 1 year ago
CMND💫 WOOHOOOOOO
👍️0
Nealio Nealio 1 year ago
Sold at 7.87 for about a double, late last night's session. Best to you...careful of possible dilution now that the RS has been done. I bought for a swing, and was playing the bottom chart before the RS, and the news event people said was coming.
👍️0
Awl416 Awl416 1 year ago
Watching mm ARCX is quite entertaining
👍️0
Nealio Nealio 1 year ago
Swing trading...my scanner says float at 600k now; could move here and quickly
👍️0
Awl416 Awl416 1 year ago
Knock knock who’s there?
👍️0
Disquisition Disquisition 1 year ago
HORRIFIC DUMPING
👍️0
81vette 81vette 1 year ago
50 to 1 reverse split,horrible news
👍️0
knrorrel knrorrel 1 year ago
that's Very interesting and sounds very seductive.:

that
7.5 million share offering closed at 0.30, we trade less than 50% of the asking price

imo


👍️0
knrorrel knrorrel 1 year ago
$CMMD 6 months ago it was $5 , BOUNCE time
https://www.stockscores.com/charts/charts/?ticker=cmnd

👍️0
knrorrel knrorrel 1 year ago
Expect good news. ?
👍️0
81vette 81vette 1 year ago
If real good news comes,watching for it
👍️0
TheFinalCD TheFinalCD 1 year ago
30 repeat? https://ih.advfn.com/stock-market/NASDAQ/clearmind-medicine-CMND/historical
Oct 11 2023 0.2263 0.0738 48.39% 0.157 0.345 0.155 63,363,303
👍️0
81vette 81vette 1 year ago
Getting attention now,thanks for letting me know bro!!
👍️0
TheFinalCD TheFinalCD 1 year ago
Clearmind Medicine Closes US$2.25 Million Public Offering
https://finance.yahoo.com/news/clearmind-medicine-closes-us-2-161600535.html

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173179438

Message in reply to:
$CMND .14 couple reasons why I like it:
7.5m share Offering @ .30 closed, we are trading less than 50% of offering price
They submitted an IND to the FDA on March 16, 2023 they are overdue to hear back from FDA, any positive news and this goes
On 10/26 there was a SC13G filed for 7.7% or 1.2m shares
At or near bottom, low risk imo, watching for breakout over .15 with sustained vol.
👍️0

Your Recent History

Delayed Upgrade Clock